- Expertise across over 20 therapeutic areas in oncology and pharma, leading teams directly and direct payer and customers interactions - An innovative problem-solving and a strategically focused expert in creating and sharing commercial and market access solutions, with hands-on experience in the Global, European and North American environment - A vibrant leader committed to achieve aggressive business objectives that maximize the brand potential - Portfolio expertize: Immunology, dermatology, rheumatology, oncology (solid tumors and hematology), neuroscience, cardiovascular & diabetes, renal, rare-diseases, respiratory, gene-therapies, infectious diseases, gastrointestinal, pain, biologics, transplant, hepatitis, SLE, Sjogrens’ portfolios; point of care and companion diagnostics - Specialties: Market Access, Pricing and Reimbursement, Health Economics Outcomes Research (HEOR), RWE
Vice President, Head of Market Access, Pricing and Policy, International at Alnylam Pharmaceuticals
MBA, International Health Care Management, Economics and Policy